Skip to main content
JIN YANG PHARMACEUTICAL. CO., LTD logo

JIN YANG PHARMACEUTICAL. CO., LTD — Investor Relations & Filings

Ticker · 007370 ISIN · KR7007370000 KO Manufacturing
Filings indexed 210 across all filing types
Latest filing 2026-05-26 Capital/Financing Update
Country KR South Korea
Listing KO 007370

About JIN YANG PHARMACEUTICAL. CO., LTD

https://www.jinyangpharm.com/

JIN YANG PHARMACEUTICAL. CO., LTD. is a company engaged in the research, development, manufacturing, and sale of pharmaceutical products, with a primary focus on prescription drugs. The company operates a fully automated, high-tech manufacturing facility. Its research and development efforts are dedicated to creating advanced preventive and therapeutic treatments for various diseases. Key areas of R&D include the development of anticancer drugs through molecular biology research, particularly for leukemia, and therapies for metabolic disorders such as diabetes and obesity. The company also develops antivirals and explores formulations based on herbal preparations.

Recent filings

Filing Released Lang Actions
전환가액의조정
Capital/Financing Update Classification · 85% confidence The document is a disclosure of the adjustment of the conversion price and the related change in the number of convertible shares for a previously issued convertible bond. This relates directly to changes in the company’s capital structure and financing terms rather than an earnings release, board changes, or a pure regulatory statement. Such an update on convertible bond terms falls under Capital/Financing Update (CAP).
2026-05-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a Korean ‘주식등의 대량보유상황보고서’ – a Large Shareholding Report filed under the Capital Markets Act that details share ownership levels and changes for a major shareholder and related parties. This is not a corporate annual or interim report, nor an earnings release, but a notification of significant shareholdings crossing reporting thresholds. It clearly fits the Major Shareholding Notification category.
2026-05-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a Korean “임원ㆍ주요주주 특정증권등 소유상황보고서” which details changes in share ownership by an officer/executive (Choi Yoon-Hwan) including dates, numbers of shares bought/sold, and resulting ownership percentages. This is a classic insider transaction disclosure by a director. Therefore, it falls under Director’s Dealing (DIRS).
2026-05-18 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled "분기보고서" (Quarterly Report) for the 49th fiscal period covering January 1, 2026 to March 31, 2026. It contains comprehensive period financial data, corporate structure, business overview, statements of capital changes, production and sales details, and substantive analysis rather than a simple announcement. This aligns with an Interim/Quarterly Report (IR) under our taxonomy. Q1 2026
2026-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a detailed report of the resolutions and voting outcomes from the company's Annual General Meeting, listing each proposal’s approval status and vote percentages. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement.
2026-03-27 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집공고). It provides updated financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, and Cash Flow Statement) as part of the management's reference materials for the upcoming shareholder meeting. Since it is a formal regulatory filing detailing the agenda and financial disclosures for an AGM, it falls under the category of AGM Information.
2026-03-19 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.